WHERE SCIENCE AND NATURE EVOLVE
Live / Applied — Response to non-final action entered (as of 13 Aug 2025)
What this means for you
Not registered yet, but its 20 Mar 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99094248
- Mark type
- Stylized text
- Filed
- 20 Mar 2025
- Attorney of record
- Adriano Pacifici
Goods and services
- Class 005 — Pharmaceuticals: Extracellular tissue matrix, namely, biological xenograft tissue grafts for transplantation into vertebrates; Biological tissue grafts; Tissue matrix, namely, biological tissue grafts in the nature of autograft, allograft, and xenograft tissue
- Class 040 — Treatment of materials: Custom production of extracellular tissue matrix, namely, xenograft tissue for transplantation into vertebrates
Owner
- NEXTGEN BIOLOGICS, INC., Alachua, FL, US
Prosecution history
- 13 Aug 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Aug 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Aug 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 13 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 23 Jul 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 Jul 2025 — NON-FINAL ACTION E-MAILED
- 23 Jul 2025 — NON-FINAL ACTION WRITTEN
- 22 Jul 2025 — ASSIGNED TO EXAMINER
- 20 Mar 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Mar 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Mar 2025 — NEW APPLICATION ENTERED